Prostate Cancer - Results from #1660

PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease. December 19, 2023

Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review. December 19, 2023

Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. December 19, 2023

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. December 19, 2023

Prostate Cancer Patient Stratification by Molecular Signatures in the Veterans Precision Oncology Data Commons. December 19, 2023

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer December 18, 2023

Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage. December 18, 2023

Blood Pressure, Hypertension, and Antihypertensive Medication Use and Risk of Total and Fatal Prostate Cancer in Black and White Men in the Atherosclerosis Risk in Communities (ARIC) Study. December 18, 2023

Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer. December 18, 2023

Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. December 18, 2023

Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes. December 18, 2023

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer. December 15, 2023

Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution. December 15, 2023

Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes. December 15, 2023

Prediction of T staging in PI-RADS 4-5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT. December 15, 2023

The PRIMARY Score: Diagnostic Performance and Added Value Compared With MRI in Detecting Clinically Significant Prostate Cancer. December 15, 2023

Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES). December 14, 2023

Prostate Cancer Risk Stratification Using Magnetic Resonance Imaging-Ultrasound Fusion versus Systematic Prostate Biopsy. December 14, 2023

Prostate Volume is A Predictor of Gleason Score Upgrading after Radical Prostatectomy in Low-Risk Prostate Cancer: A Systematic Review and Meta-analysis. December 14, 2023

Network connectivity between psychological resilience and depression in prostate cancer patients. December 14, 2023

Page 84 of 1436